tomeko

Erythropoietic uroporphyria associated with myeloid malignancy

Just diagnosed with Erythropoietic uroporphyria associated with myeloid malignancy?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Erythropoietic uroporphyria associated with myeloid malignancy, look for clinical trials, and connect with others living with it — all in one place.

Open the full Erythropoietic uroporphyria associated with myeloid malignancy hub →

Overview

Erythropoietic uroporphyria associated with myeloid malignancy is a rare condition. Tomeko brings together the specialists, research, clinical trials, treatments and community for Erythropoietic uroporphyria associated with myeloid malignancy so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:280379 · ICD-10 E80.2 · GARD 0010948

Find care for Erythropoietic uroporphyria associated with myeloid malignancy

Authoritative references for Erythropoietic uroporphyria associated with myeloid malignancy

Common questions

I was just diagnosed with Erythropoietic uroporphyria associated with myeloid malignancy — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Erythropoietic uroporphyria associated with myeloid malignancy, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Erythropoietic uroporphyria associated with myeloid malignancy?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Erythropoietic uroporphyria associated with myeloid malignancy, filtered to your area.

Are there clinical trials for Erythropoietic uroporphyria associated with myeloid malignancy?

Tomeko shows live, recruiting studies for Erythropoietic uroporphyria associated with myeloid malignancy from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com